How a Cancer Diagnosis Changes Your Medicare Situation
When someone receives a cancer diagnosis, their healthcare needs shift dramatically. Medicare coverage is often one of the first concerns for people newly diagnosed with cancer, especially since treatment costs can be substantial. Understanding how Medicare responds to a cancer diagnosis—and what changes may occur in coverage—helps people make informed decisions about their medical care.
Free Guide to Growing Palm Trees From Seeds →
A cancer diagnosis itself does not automatically change your Medicare coverage status. Medicare eligibility is based on age, disability status, or end-stage renal disease. However, a cancer diagnosis may have indirect effects on your Medicare situation. For example, if you are under 65 and not yet on Medicare, a cancer diagnosis may make you eligible for Social Security Disability Insurance (SSDI), which can lead to Medicare coverage after 24 months of receiving SSDI benefits. Additionally, certain cancers and treatments may qualify someone for expedited consideration of disability status.
People already enrolled in Medicare will continue their existing coverage during cancer treatment. Original Medicare (Part A and Part B) covers many cancer-related services, including hospital stays, doctor visits, chemotherapy drugs administered in clinical settings, and radiation therapy. Medicare Advantage plans (Part C) must cover at least the same services as Original Medicare, though they may have different cost structures and provider networks.
The financial impact of cancer treatment is often substantial. According to the American Cancer Society, a cancer diagnosis can result in treatment costs ranging from tens of thousands to hundreds of thousands of dollars depending on the type, stage, and treatment method. While Medicare covers many services, out-of-pocket costs such as copayments, coinsurance, and deductibles can still accumulate quickly.
Practical Takeaway: If you have been diagnosed with cancer and are approaching age 65, or if you are under 65 and believe cancer may affect your ability to work, contact Social Security to learn about your current Medicare status and any changes that may result from your diagnosis. Review your current Medicare plan documents to understand which cancer treatments and providers are covered.
What Medicare Part A and Part B Cover for Cancer Care
Original Medicare consists of Part A (hospital insurance) and Part B (medical insurance). Both parts play important roles in cancer treatment coverage. Part A covers inpatient hospital care, skilled nursing facility care following a hospital stay, home health services, and hospice care. Part B covers outpatient services, including doctor visits, diagnostic tests, lab work, imaging (such as CT scans and MRI), and various treatments.
Learn About Getting a Fishing License in Illinois →
For cancer patients, Part A typically covers hospital admissions for surgery, chemotherapy infusions that require hospitalization, and treatment of cancer-related complications. If a cancer patient needs extended care after hospitalization—such as rehabilitation or skilled nursing care—Part A may cover these services for up to 100 days in a skilled nursing facility (after meeting the Part A deductible and spending requirements).
Part B covers oncologist visits, radiologist consultations, diagnostic imaging, laboratory tests, and certain medications. Chemotherapy administered in an outpatient setting, such as a cancer center or doctor's office, is covered under Part B. Part B also covers radiation therapy, hormone therapy, and some targeted cancer drugs. However, Part B coverage for medications has specific rules. Chemotherapy drugs administered by injection in a medical facility are generally covered, while oral cancer medications fall under Part D (prescription drug coverage).
According to Medicare data, cancer patients utilizing both Part A and Part B services incur significant costs even with coverage. After meeting the Part A deductible (which was $1,556 for 2024), patients pay coinsurance for hospital stays. Part B requires a deductible ($240 for 2024) and then typically 20% coinsurance for most services. These out-of-pocket costs can add up during extended treatment periods.
Genetic testing and counseling related to cancer risk—such as BRCA testing for breast cancer predisposition—are covered by Part B when ordered by a healthcare provider and medically necessary. This coverage can be valuable, as genetic testing can inform treatment decisions and may prevent future cancers.
Practical Takeaway: Before beginning cancer treatment, ask your oncology team which specific services will be provided in inpatient versus outpatient settings. This will help you understand whether costs will primarily be covered by Part A or Part B. Keep a record of all deductibles you have met each year, as this information affects your out-of-pocket costs.
How Prescription Drug Coverage (Part D) Works for Cancer Medications
Oral cancer medications—pills and capsules taken at home—are covered under Medicare Part D, the prescription drug plan, rather than Part B. This includes medications such as targeted therapies and some immunotherapies. Understanding Part D coverage is essential because cancer drugs are often expensive, and coverage rules can directly affect your ability to afford treatment.
Learn About Replacing Your Missing Driver's License →
Part D plans are offered by private insurance companies approved by Medicare. Each plan has a formulary, which is a list of covered medications. Some cancer drugs may be on one plan's formulary but not another's. Part D coverage involves several phases: an initial coverage phase, a coverage gap (often called the "donut hole"), and catastrophic coverage. In 2024, after you and your plan pay a combined total of $5,030 in drug costs, you enter the coverage gap. Once total out-of-pocket spending reaches $8,000, catastrophic coverage begins, where you pay only about 5% of drug costs for the rest of the year.
Cancer medications may require prior authorization, which means your doctor must obtain approval from your Part D plan before the medication is covered. Some plans use step therapy, requiring you to try certain medications first before covering others. For expensive cancer drugs, Part D plans may place them in higher cost-sharing tiers, meaning you pay a larger percentage of the drug cost.
If your cancer medication is not covered by your current Part D plan, you have options. During the annual open enrollment period (October 15 to December 7), you can switch to a different Part D plan that does cover your medication. You can also ask your doctor about requesting an exception from your plan, which may allow coverage of a non-formulary drug under certain circumstances. Additionally, pharmaceutical companies often offer patient assistance programs for expensive cancer medications, which may reduce your out-of-pocket costs regardless of your Part D coverage.
The National Cancer Institute reports that the cost of oral cancer medications can range from $4,000 to $12,000 per month or more. This makes understanding your Part D coverage and out-of-pocket costs critically important for cancer patients.
Practical Takeaway: Obtain your prescribed cancer medication's price and insurance requirements before beginning treatment. Contact your Part D plan to confirm coverage and any prior authorization needs. Ask your doctor about generic alternatives and patient assistance programs if the medication is not covered or carries high out-of-pocket costs.
Medicare Advantage Plans and Cancer Treatment Coverage
Medicare Advantage plans (Part C) are an alternative to Original Medicare. Private insurance companies offer these plans, which must cover all services that Original Medicare covers—including cancer treatment—but may do so differently. Medicare Advantage plans often include prescription drug coverage (Part D) built into the plan, along with additional benefits like dental or vision care.
Learn How to Use Your EBT Card at ATMs →
For cancer patients, a key difference between Medicare Advantage and Original Medicare is the network requirement. Most Medicare Advantage plans use networks of doctors and hospitals. If you receive treatment from an out-of-network provider, you may pay higher costs or the services may not be covered. This can be problematic if your cancer treatment requires specialists outside your plan's network. Some Medicare Advantage plans offer out-of-network coverage for emergencies or for certain specialists, but this must be verified with your plan.
Another important difference is the annual out-of-pocket maximum. Medicare Advantage plans are required to have an out-of-pocket maximum (for 2024, ranging from $6,700 to $10,000 depending on the plan). Once you reach this maximum through copayments, coinsurance, and deductibles, the plan covers 100% of additional covered services for the rest of the year. Original Medicare does not have an out-of-pocket maximum, meaning costs can continue to accumulate indefinitely. For cancer patients requiring extended, expensive treatment, this out-of-pocket maximum can provide significant financial protection.
If you have a Medicare Advantage plan and are diagnosed with cancer, you have the option to switch to Original Medicare during a special enrollment period triggered by a significant change in health status. This allows you to ensure you have access to any oncologist or hospital you choose, without network restrictions. However,